title: Early and Severe Radiation Esophagitis Associated With Concurrent Sirolimus.
authors.affiliation: Pritzker School of Medicine, University of Chicago, Chicago, IL.
authors.forename: Adil S
authors.initials: AS
authors.lastname: Akthar
authors.affiliation: Pritzker School of Medicine, University of Chicago, Chicago, IL dgolden@radonc.uchicago.edu.
authors.forename: Daniel W
authors.initials: DW
authors.lastname: Golden
authors.affiliation: Pritzker School of Medicine, University of Chicago, Chicago, IL.
authors.forename: Rita
authors.initials: R
authors.lastname: Nanda
authors.affiliation: Pritzker School of Medicine, University of Chicago, Chicago, IL.
authors.forename: Manish R
authors.initials: MR
authors.lastname: Sharma
authors.affiliation: Pritzker School of Medicine, University of Chicago, Chicago, IL.
authors.forename: Helen S
authors.initials: HS
authors.lastname: Te
authors.affiliation: Pritzker School of Medicine, University of Chicago, Chicago, IL.
authors.forename: K Gautham
authors.initials: KG
authors.lastname: Reddy
authors.affiliation: Pritzker School of Medicine, University of Chicago, Chicago, IL.
authors.forename: Xuefeng
authors.initials: X
authors.lastname: Zhang
authors.affiliation: Pritzker School of Medicine, University of Chicago, Chicago, IL.
authors.forename: Renuka
authors.initials: R
authors.lastname: Malik
mesh_terms: D000328:Adult; D006528:Carcinoma, Hepatocellular / Q000628:therapy; D004941:Esophagitis / Q000139:chemically induced / Q000209:etiology*; D017809:Fatal Outcome; D006801:Humans; D008113:Liver Neoplasms / Q000628:therapy; D008297:Male; D009447:Neuroblastoma / Q000628:therapy; D011832:Radiation Injuries / Q000139:chemically induced / Q000209:etiology*; D011838:Radiation-Sensitizing Agents / Q000009:adverse effects* / Q000627:therapeutic use; D020123:Sirolimus / Q000008:administration & dosage* / Q000627:therapeutic use
chemical_list: D011838:Radiation-Sensitizing Agents; D020123:Sirolimus